Bionovis was born in 2012, from the union between the renowned Brazilian laboratories Aché, EMS, Hypera Pharma and União Química. As a pharmaceutical biotechnology joint venture, we have become leaders and pioneers in the national production of highly complex biological medicines and biosimilars.

We have established collaborations with prominent global players in the sector and prominent public laboratories in Brazil. Through these strategic alliances, we acquire advanced technologies for the manufacture of innovative biopharmaceuticals, biosimilars and biobetters.

Today, some of our biopharmaceuticals are in an advanced stage of technology transfer and already serve the Ministry of Health, providing access to high standard therapies in the entire Brazilian territory. This movement reinforces our commitment and position in strengthening the pharmaceutical biotechnology sector in Brazil.